Sonic Clinical Trials
Sonic Clinical Trials is a global central laboratory services provider supporting Phase I-IV clinical trials and safety testing for pharmaceutical, biotechnology, CRO, and medical device sponsors, operating from four central labs and the Sonic Healthcare diagnostic network.
- Company typePrivate
- Founded1994
- HeadquartersSydney, Australia
- Headcount51–100
- GTM typeB2B
- OfferingServices
What Sonic Clinical Trials does
Sonic Clinical Trials (SCT) is a central laboratory services provider dedicated to supporting Phase I-IV clinical trials and safety testing for pharmaceutical, biotechnology, CRO, and medical device sponsors worldwide. Founded in 1994 as a division of Sonic Healthcare and operating under the legal entity Sonic Clinical Trials Pty Ltd, the company runs owned central laboratories in Sydney, Austin, Antwerp, and London, and leverages Sonic Healthcare's Australian diagnostic network (Sydney, Melbourne, Brisbane, Adelaide, Perth) for local laboratory services. Its service portfolio spans routine and esoteric testing (biochemistry, haematology, microbiology, endocrinology, molecular biology, pharmacogenomics, biomarker analysis), sample management with cold chain logistics, kit production and automatic resupply, project management, and data management. The technology backbone consists of the proprietary Artemis Laboratory Information Management System (LIMS) for managing kits, logistics, sample analysis, blinding, and reference ranges, integrated with the Sonic Realtime digital portal for near real-time, browser-based study data access. The company is an accredited Research Service Provider under the Australian R&D Tax Incentive program, allowing eligible clients to claim up to 45% R&D tax offsets.
The business operates as a B2B enterprise with quote-based, multi-year contracted service agreements tailored to study complexity, volume, and geographic scope. Go-to-market relies on direct enterprise sales through a dedicated business development function, supplemented by participation in major industry events (BIO International, DIA Global, ARCS, Outsourcing in Clinical Trials Europe, Knowledge For Growth). Revenue is not publicly disclosed. SCT maintains a broad portfolio of accreditations (NATA ISO/IEC 17025, CAP, CMS/CLIA, NGSP, CDC Lipid Standardisation, UKAS, FDA 21 CFR Part 11, TGA, ICH GCP) that serve as a core competitive barrier, while benefiting from the global infrastructure, capital access, and brand of its publicly listed parent, Sonic Healthcare, which ranks in the top 50 on the ASX and serves more than 100 million patients annually.
Sonic Clinical Trials firmographics
Firmographics- Name
- Sonic Clinical Trials
- Legal name
- Sonic Clinical Trials Pty Ltd
- Website
- https://sonicclinicaltrials.com.au
- Company type
- Private
- Founded year
- 1994
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- Sonic Clinical Trials is a global central laboratory services provider supporting Phase I-IV clinical trials and safety testing for pharmaceutical, biotechnology, CRO, and medical device sponsors, operating from four central labs and the Sonic Healthcare diagnostic network.
- Ownership category
- akta.pro rank
Sonic Clinical Trials industry classification
Industry- Product category
- Clinical Trial Laboratory Services
- NAICS
- Medical Laboratories (621511), Medical and Diagnostic Laboratories (6215)
- SIC
- Services-Medical Laboratories (8071)
- akta.pro primary industry
- Point-of-Care & Decentralized Trial Testing Services (HLAGAEAK)
- akta.pro secondary industries
- Clinical Biomarker Testing Services (central labs, trial enrollment/monitoring assays) (HLAAAMAC), Bioanalytical Testing (PK/ADA/NAb) (HLAGADAA), Reference & Esoteric Testing Laboratories (HLAFAMAJ), Clinical Development (Phase I–III Trial Design & Execution) (HLAIALAE)
Keywords
Where Sonic Clinical Trials is headquartered
LocationHeadquarters
- HQ city
- Sydney
- HQ country
- Australia
- HQ region
- Oceania
Offices8 records
Markets served
Sonic Clinical Trials business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Supply Chain, Technology or R&D, Infrastructure, Marketing or Sales
Revenue model
- Central Laboratory Services: Sonic Clinical Trials generates revenue through providing comprehensive central laboratory testing services to pharmaceutical, biotech, and CRO clients conducting clinical trials. Services include routine and esoteric testing, sample management, kit production, logistics, and data management. Revenue is derived from contracted service agreements for Phase I-IV clinical trials.
- Research Service Provider (RSP): As an accredited Research Service Provider under the Australian Government's R&D Tax Incentive program, SCT enables eligible companies to claim R&D tax offsets for expenditure on registered R&D activities conducted by SCT.
- Local Laboratory Services: Provides flexible local laboratory data solutions using Australia's largest diagnostic laboratory network (Sydney, Melbourne, Brisbane, Adelaide, Perth) for faster, more streamlined patient data management particularly in early-phase and acute care studies.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Enterprise B2B service contracts for pharmaceutical and biotech clients |
Go-to-market motion2 records
Distribution channels3 records
Marketing channels4 records
Sonic Clinical Trials product offering
Product offeringCore offering
Sonic Clinical Trials (SCT) is a global central laboratory that provides comprehensive testing, sample management, kit production, logistics, and data management services exclusively for Phase I-IV clinical trials. It serves pharmaceutical, biotechnology, and contract research organisations with central laboratory services backed by proprietary Artemis LIMS and the Sonic Realtime digital portal, plus local laboratory services delivered through Sonic Healthcare's diagnostic network.
Product overview
Sonic Clinical Trials provides comprehensive central laboratory services for Phase I-IV clinical trials and safety testing for pharmaceutical, biotechnology, and research organisations worldwide. The core technology platform consists of the Artemis LIMS for integrated laboratory information management, complemented by the Sonic Realtime® digital platform for real-time data access and reporting. Their service portfolio encompasses laboratory services (biochemistry, haematology, microbiology, immuoserology, endocrinology, drug screening, cytology, molecular biology, histology, pharmacogenomics, biomarker analysis), scientific affairs, sample management with cold chain storage capabilities, kit production and logistics with automatic resupply, site support and project management, data management with validated electronic systems, quality assurance, and Research Service Provider services. Additionally, a dedicated Local Laboratory and Special Projects division provides flexible local laboratory data solutions and specialized services including Phase 1 local laboratory services, acute care studies, biomarker development, specialty sample processing, diagnostics-to-market support, and custom biorepository services.
Differentiator
Problem solved
Functional benefit
Brands
- Sonic Realtime: Digital e-request solution providing continuous access to study data and patient lab results through a secure online portal.
Products and services
- Central Laboratory Services Comprehensive central laboratory testing and support services for Phase I-IV clinical trials, including routine and esoteric testing (biochemistry, haematology, microbiology, immuneserology, endocrinology, drug screening, cytology, molecular biology, histology, pharmacogenomics, biomarker analysis), sample management, kit production, logistics, site support, project management, and data management. Delivered to pharmaceutical, biotechnology, and CRO clients globally through central laboratories in Sydney, Austin, Antwerp, and London.
- Local Laboratory Services Flexible local laboratory data solutions provided through Sonic Healthcare's Australian diagnostic network (Sydney, Melbourne, Brisbane, Adelaide, Perth). Designed for early-phase and acute care studies requiring faster, more streamlined patient data management with seamless integration to central laboratory data.
- Special Projects Specialized clinical trial laboratory services including biomarker development, specialty sample processing, diagnostics-to-market support, custom biorepository services, and Phase 1 and acute care study support. Targeted at clients with bespoke or non-standard trial requirements.
- Research Service Provider (RSP) Services Accredited Research Service Provider services under the Australian Government's R&D Tax Incentive program, enabling eligible companies to claim R&D tax offsets (up to 45%) for eligible expenditure on registered R&D activities conducted by Sonic Clinical Trials.
- Sonic Realtime Digital e-request solution providing continuous, near real-time access to study data and patient lab results through any major web browser. Integrated with Artemis LIMS, with study-specific reference ranges, alerts, and data blinding, secured by 128-bit SSL encryption. Provided to enterprise clinical trial clients as part of SCT's central laboratory services.
Quantifiable outcome
- ~95% of laboratory testing performed within Sonic group of laboratories
- +1 more outcomes
Companies that use Sonic Clinical Trials
Customer profileNamed customers4 records
Segments4 records
Ideal customer profiles4 records
Sonic Clinical Trials technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
Sonic Clinical Trials partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Sonic HealthcarecoreSonic Clinical Trials is a wholly owned subsidiary of Sonic Healthcare, one of the world's largest specialist medical diagnostics companies. This parent company relationship provides SCT with access to global laboratory infrastructure, diagnostic resources, medical expertise, and the extensive Sonic Healthcare network of laboratories across Australia, USA, Germany, Switzerland, UK, Belgium, and New Zealand.
Scale indicators5 records
Recent moves6 records
Expansion highlights6 records
Sonic Clinical Trials competitors and assessment
Company assessmentDirect peers
- ACM Global Laboratories: ACM Global Laboratories is an independent central lab providing Phase I–IV safety testing, biomarker and specialty testing with operations across the US, UK, Europe, India, and Singapore. Its focus on safety testing and central lab services for global trials makes it a direct peer to SCT.
- Eurofins Central Laboratory: Eurofins Central Laboratory operates end-to-end central lab services for Phase I–IV clinical trials across multiple continents with harmonized SOPs, kit production, and logistics — directly comparable to SCT's central laboratory service model across pharma, biotech, and CRO customers.
- LabCorp Drug Development (Fortrea): Fortrea (the clinical development business spun out from LabCorp Drug Development) operates central laboratory, bioanalytical, and biomarker services integrated with broader CRO functions — directly competitive with SCT for global pharma/biotech central lab contracts.
- Q² Solutions: Q² Solutions is a central laboratory joint venture between IQVIA and Quest Diagnostics that provides safety, biomarker, bioanalytical, and genomic lab services for clinical trials. It is the closest comparable to SCT given its global multi-region central lab footprint, biomarker and PK/PD testing, and direct competition for pharma/biotech/CRO sponsors.
Emerging players
- Boca Biolistics / reference lab niche players: Niche specialty reference laboratories focused on bioanalytical, specialty biomarker, and esoteric testing services overlap with SCT's specialty/PK/biomarker testing capabilities, often addressing similar biotech customers with narrower specialty menus.
- Worldwide Clinical Trials: Worldwide Clinical Trials is a mid-sized CRO with bioanalytical and central lab capabilities serving small to mid-sized pharma/biotech sponsors across rare disease and specialty therapy areas — a partial-overlap peer to SCT on the central lab side of clinical trial support.
Broad incumbents
- Medpace: Medpace is a mid-sized global CRO with embedded laboratory and biomarker services supporting biotech and small-mid pharma sponsors across Phase I–IV trials — comparable to SCT in customer profile and trial phase coverage, though central lab is one component of a broader CRO model.
- PPD (Thermo Fisher Scientific): PPD's clinical research services, now part of Thermo Fisher, include central laboratory and bioanalytical operations supporting global clinical trials. Comparable to SCT in central lab capabilities but bundled within a much larger CRO and life sciences tools platform.
- ICON plc (formerly PRA Health/CRL Clinical): ICON is one of the largest global CROs with embedded central laboratory and bioanalytical capabilities serving similar pharma and biotech customers across Phase I–IV trials. It competes with SCT primarily via its broader CRO-service bundling, even though central lab work is one piece of a much wider portfolio.
Others
- Sonic Healthcare (parent): Sonic Healthcare is the parent company of SCT. While not a peer in the competitive sense, its broader diagnostic pathology network underpins SCT's local lab service capabilities and represents the most operationally intertwined comparable in the diagnostic-central lab space.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat6 records
Key risks5 records
Key highlights7 records
Customer concentration
Sonic Clinical Trials social profiles
Digital presenceSonic Clinical Trials compliance and trust
Trust signalCompliance10 records
Sonic Clinical Trials financial estimates
Financial estimateRevenue estimate
Valuation estimate
Sonic Clinical Trials leadership team
Management profileNumber of profiles
Profiles12 records
Sonic Clinical Trials funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Sonic Clinical Trials M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Sonic Clinical Trials
What does Sonic Clinical Trials do?
Sonic Clinical Trials (SCT) is a global central laboratory that provides comprehensive testing, sample management, kit production, logistics, and data management services exclusively for Phase I-IV clinical trials. It serves pharmaceutical, biotechnology, and contract research organisations with central laboratory services backed by proprietary Artemis LIMS and the Sonic Realtime digital portal, plus local laboratory services delivered through Sonic Healthcare's diagnostic network.
Is Sonic Clinical Trials a public or private company?
Sonic Clinical Trials is a private company. It is classified as corporate owned and is currently operating.
When was Sonic Clinical Trials founded?
Sonic Clinical Trials was founded in 1994. It employs 51 to 100 people.
Where is Sonic Clinical Trials based?
Sonic Clinical Trials is headquartered in Sydney, Australia, in the Oceania region.
How does Sonic Clinical Trials make money?
Three revenue lines are on record. Central Laboratory Services are the primary driver. The others are research Service Provider (RSP) and local Laboratory Services.
Who are Sonic Clinical Trials's main competitors?
Direct peers on record are ACM Global Laboratories, Eurofins Central Laboratory, LabCorp Drug Development (Fortrea) and Q² Solutions. Emerging players are Boca Biolistics / reference lab niche players and Worldwide Clinical Trials. Broad incumbents are Medpace, PPD (Thermo Fisher Scientific) and ICON plc (formerly PRA Health/CRL Clinical). Sonic Healthcare (parent) is listed as an others.
Does Sonic Clinical Trials have an API?
No public API is recorded for Sonic Clinical Trials.
What industry is Sonic Clinical Trials in?
Sonic Clinical Trials's product category is Clinical Trial Laboratory Services. Its primary akta.pro industry code is HLAGAEAK, Point-of-Care & Decentralized Trial Testing Services, with a secondary code of HLAAAMAC, Clinical Biomarker Testing Services (central labs, trial enrollment/monitoring assays). Its NAICS code is 621511 and its SIC code is 8071.